Resoimplant GmbH closes €2.54 third financing round

Funding

Resoimplant GmbH of Regensburg has attracted a new investor, the Bavarian Investment Company (Bayerische Beteiligungsgesellschaft) to join the existing shareholders, S-Refit, Regensburg; High Tech Gründerfonds, Bonn; Bayern Kapital, Landshut and FVW Beteiligungsgesellschaft GmbH, Essen; in a €2.54 million third round.

The funds will be used to develop international sales and marketing and accelerate the new product pipeline, in particular a new fixation system for use in shoulder and ankle surgery.

Resoimplant develops, manufactures and markets resorbable double shell expansion systems for secure fixation of tendons, ligaments and bone fragments in orthopaedic, trauma and sports medicine applications. The design uses a polymer which is completely re-absorbed, meaning there is no need for a second operation to remove the implant.

“This and a new design protected by over 30 patents worldwide assure a technological differentiation for Resoimplant,” said Peter Pauli of BayBG Geschäftsführer, of the new investment. “In contrast to other resorbable products on the market, which are practically all copies of metal screw-type implants, the Resoimplant products are distinctly different, using a patented expansion technology which has been proven in many fields in the past decades to improve treatment.”

“We are extremely pleased to be one of the very few medtech companies in Europe to close a financing round in these difficult economic conditions,” said Resoimplant general manager Robert Guilleaume. “This investment allows use to introduce our new Resofix Plus system in the key markets in the US and in Europe.”